Design and in vitro/in vivo evaluation of extended release matrix tablets of nateglinide.
Sharma PR, Lewis SA.
J Young Pharm · research-article; journal article · DOI 10.1016/j.jyp.2013.11.003 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för nateglinide. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
18 träffarCharacterization of monocarboxylate transporter 6: expression in human intestine and transport of the antidiabetic drug nateglinide.
Kohyama N, Shiokawa H, Ohbayashi M, Kobayashi Y, Yamamoto T.
Drug Metab Dispos · research support, non-u.s. gov't; journal article · DOI 10.1124/dmd.113.051854II. Technological approaches to improve the dissolution behavior of nateglinide, a lipophilic insoluble drug: co-milling.
Maggi L, Bruni G, Maietta M, Canobbio A, Cardini A, Conte U.
Int J Pharm · journal article · DOI 10.1016/j.ijpharm.2013.06.085I. Technological approaches to improve the dissolution behavior of nateglinide, a lipophilic insoluble drug: nanoparticles and co-mixing.
Maggi L, Bruni G, Maietta M, Canobbio A, Cardini A, Conte U.
Int J Pharm · journal article · DOI 10.1016/j.ijpharm.2013.06.084Lyophilized oral sustained release polymeric nanoparticles of nateglinide.
Kaleemuddin M, Srinivas P.
AAPS PharmSciTech · research-article; journal article · DOI 10.1208/s12249-012-9887-zSimultaneous determination of metformin, nateglinide and gliclazide in pharmaceutical preparations using micellar liquid chromatography.
El-Wasseef DR.
Int J Biomed Sci · research-article; journal articleQuo vadis nateglinide? Ten-year perspective.
Grunberger G.
Expert Opin Pharmacother · review; journal article · DOI 10.1517/14656566.2011.600305Safety and efficacy of nateglinide/metformin combination therapy in the treatment of type 2 diabetes.
Israel MK, Istvan E, Baron MA.
Vasc Health Risk Manag · review-article; review; journal article · DOI 10.2147/vhrm.s2718Effects of antidiabetic drugs on dipeptidyl peptidase IV activity: nateglinide is an inhibitor of DPP IV and augments the antidiabetic activity of glucagon-like peptide-1.
Duffy NA, Green BD, Irwin N, Gault VA, McKillop AM, O'Harte FP, Flatt PR.
Eur J Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejphar.2007.05.010Drug-drug and food-drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinide.
Scheen AJ.
Clin Pharmacokinet · review; journal article · DOI 10.2165/00003088-200746020-00001A review of nateglinide in the management of patients with type 2 diabetes.
Tentolouris N, Voulgari C, Katsilambros N.
Vasc Health Risk Manag · review-article; review; journal articleNateglinide--current and future role in the treatment of patients with type 2 diabetes mellitus.
Campbell IW.
Int J Clin Pract · review; journal article · DOI 10.1111/j.1368-5031.2005.00669.xClinical pharmacokinetics of nateglinide: a rapidly-absorbed, short-acting insulinotropic agent.
McLeod JF.
Clin Pharmacokinet · review; journal article · DOI 10.2165/00003088-200443020-00003Nateglinide (Starlix): update on a new antidiabetic agent.
Phillips LS, Dunning BE.
Int J Clin Pract · review; journal articleThe mechanisms underlying the unique pharmacodynamics of nateglinide.
Hu S, Boettcher BR, Dunning BE.
Diabetologia · review; journal article · DOI 10.1007/s00125-002-0935-1Nateglinide therapy for type 2 diabetes mellitus.
Levien TL, Baker DE, Campbell RK, White JR.
Ann Pharmacother · review; journal article · DOI 10.1345/aph.1a061Nateglinide: a new rapid-acting insulinotropic agent.
Hanif W, Kumar S.
Expert Opin Pharmacother · review; journal article · DOI 10.1517/14656566.2.6.1027Senaglinide. A 4166, AY 4166, Fastic, SDZ DJN 608, Starlix, Starsis, YM 026, Nateglinide.
Författaruppgift saknas
Drugs R D · journal article · DOI 10.2165/00126839-199902020-00011